CUSIP 12529R107COM STKCCCCQ4 2025
58 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | 9.44M | $18.03M |
| 2 | Morgan Stanley | 8.98M | $17.15M |
| 3 | Ra Capital Management, L.P. | 8.00M | $15.28M |
| 4 | Bain Capital Life Sciences Investors, LLC | 7.17M | $13.70M |
| 5 | Lynx1 Capital Management LP | 7.10M | $13.56M |
| 6 | Vanguard Group Inc | 4.38M | $8.37M |
| 7 | Wasatch Advisors LP | 4.34M | $8.30M |
| 8 | Soleus Capital Management, L.P. | 3.80M | $7.27M |
| 9 |
| 4 | Feb 11, 2026 | Morgan Stanley | 13G/A | 9.3% | 8.97M | SEC |
| 5 | Nov 14, 2025 | Orbimed Advisors LLC | 13G/A | 5.0% | 16.67T | SEC |
| 6 | Nov 13, 2025 | Wasatch Advisors LP | 13G/A | 6.8% | 4.85M | SEC |
| 7 | Oct 24, 2025 | Ra Capital Management, L.P. | 13G | 9.9% | 9.44M | SEC |
| 8 | Oct 24, 2025 | Bain Capital Life Sciences Fund II, L.P. | 13G | 6.3% | 6.06M | SEC |
| 9 | Oct 20, 2025 | Point72 Asset Management, L.P. | 13G | 9.9% | 22.65M | SEC |
| 10 | Aug 7, 2025 | Morgan Stanley | 13G/A | 6.7% | 4.75M | SEC |
See the full Schedule 13D/13G history for C4 Therapeutics Inc.
Unlock full history| Bank Of America Corp /De/ |
| 2.39M |
| $4.56M |
| 10 | Silverarc Capital Management, LLC | 1.99M | $3.81M |